Anemia as a risk factor for cardiac disease in dialysis patients

Seminars in Dialysis

Volumn 12, Issue 2, 1999, Pages 84-86

  Foley, Robert N ^a   Parfrey, Patrick S ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003632660     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139X.1999.00013.x     Document Type: Article

References (8)

1. Katz AM: The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart. Ann Intern Med 121:363-371, 1994
2. Barren BJ, Parfrey PS, Morgan J, Barre P, Fine A, Goldstein MB, Handa SP, Jindal KK, Kjellstrand CM, Levin A, Mandin H, Muirhead N, Richardson RM: Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 29:214-222, 1997
3. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27:347-354, 1996
4. Hutchinson TA, Thomas DC, MacGibbon B: Predicting survival in adults with end-stage renal disease: An age equivalence index. Ann Intern Med 96:417-423. 1982
5. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
6. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-staee renal disease. Kidney Int 36: 285-290, 1989
7. Foley PN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186-192, 1995
8. Foley RN, Parfrey PS, Harriett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024-2031, 1995